These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10146990)

  • 1. Drug treatment of pneumonia in the elderly: efficacy and costs.
    Saltiel E; Weingarten S
    Pharmacoeconomics; 1993 Apr; 3(4):268-75. PubMed ID: 10146990
    [No Abstract]   [Full Text] [Related]  

  • 2. To Discharge or Not to Discharge on Outpatient Parenteral Antimicrobial Therapy: That Is the Question.
    Markham JL; Goldman JL
    Hosp Pediatr; 2019 Apr; 9(4):314-316. PubMed ID: 30885920
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicare coverage of outpatient ambulatory intravenous antibiotic therapy: a program that pays for itself.
    Tice AD; Poretz D; Cook F; Zinner D; Strauss MJ
    Clin Infect Dis; 1998 Dec; 27(6):1415-21. PubMed ID: 9868653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic utilization and cost analysis in hospitalized patients with community-acquired pneumonia.
    Stein GE; Mantz SL
    Hosp Pharm; 1995 Feb; 30(2):132-4, 137. PubMed ID: 10140526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Costs and benefits.
    Milkovich G
    Hosp Pract (Off Ed); 1993 Jun; 28 Suppl 1():39-43. PubMed ID: 8505397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
    Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
    Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreasing out-of-pocket costs of antibiotics: the good, the bad, and the unknown.
    Hersh AL; Gonzales R
    Arch Intern Med; 2010 Aug; 170(15):1314-6. PubMed ID: 20696954
    [No Abstract]   [Full Text] [Related]  

  • 8. How long a stay in the hospital is needed for patients with community-acquired pneumonia?
    Siegel RE
    Am J Med; 2000 Oct; 109(5):434-6. PubMed ID: 11020402
    [No Abstract]   [Full Text] [Related]  

  • 9. Daily cost of delay to adequate antibiotic treatment among patients surviving a hospitalization with community-onset Acinetobacter baumannii pneumonia or sepsis.
    Zilberberg MD; Nathanson BH; Sulham K; Fan W; Shorr AF
    Crit Care; 2017 Jun; 21(1):130. PubMed ID: 28583148
    [No Abstract]   [Full Text] [Related]  

  • 10. Economic evaluation of oral ofloxacin versus standard parenteral therapy in the treatment of pneumonia.
    Menzin J; Huse DM; Richner R; Oster G
    Pharmacoeconomics; 1992 Aug; 2(2):171-7. PubMed ID: 10146956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare reimbursement for outpatient intravenous antibiotics.
    Am J Hosp Pharm; 1985 Aug; 42(8):1712. PubMed ID: 3898827
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-acquired pneumonia. Cost-effective antimicrobial therapy.
    Cunha BA
    Postgrad Med; 1996 Jan; 99(1):109-10, 113-4, 117-9, passim. PubMed ID: 8539197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral antibiotics: practical prescribing rules for practitioners.
    McCue JD
    Geriatrics; 1992 Jul; 47(7):59-60, 65-6. PubMed ID: 1618399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effective treatment of lower respiratory tract infections.
    Garrelts JC; Herrington AM
    Pharmacoeconomics; 1996 Jul; 10(1):36-58. PubMed ID: 10160469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriate selection of antimicrobials in the treatment of ambulatory patients.
    Goetz MB
    Health Syst Lead; 1994 Oct; 1(8):34-8. PubMed ID: 10140124
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cost-effectiveness analysis of ambulatory treatment for adult patients with community-acquired pneumonia: according to Japanese Respiratory Society guidelines].
    Morimoto T; Koyama H; Shimbo T; Fukui T
    Nihon Kokyuki Gakkai Zasshi; 2002 Jan; 40(1):17-25. PubMed ID: 11925912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pneumonia in the antibiotic era].
    He L
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Apr; 22(4):197-8. PubMed ID: 11775912
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.
    Marras TK; Nopmaneejumruslers C; Chan CK
    Am J Med; 2004 Mar; 116(6):385-93. PubMed ID: 15006587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment: cost-effectiveness of macrolides in lower respiratory tract infections.
    Renz CL; Ashraf T
    Ann Pharmacother; 2000 Oct; 34(10):1206-7. PubMed ID: 11054992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.